Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,093-1,104 of 4,306
Drug study icon
CompletedNCT01244828

Asenapine for schizophrenia

This study is completed. It is testing asenapine for schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.Over 20 Years
Countries
Sponsor
Organon and Co
Condition
Schizophrenia
Drug study icon
CompletedNCT02335658

Long-term Study of DSP-5423P in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Tokyo
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
Japan
Sponsor
Sumitomo Pharma Co., Ltd.
Condition
Schizophrenia
Drug study icon
CompletedNCT01626872

Long-Term Study of MP-214 in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Sapporo
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 20 Years to 65 Years
Countries
Japan, South Korea, Taiwan
Sponsor
Tanabe Pharma Corporation
Condition
Schizophrenia
Drug study icon
CompletedNCT04959032

Lumateperone for the Prevention of Relapse in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States, Bulgaria, Poland, ...
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT06527885

Lurasidone Non-Interventional Study in Schizophrenia Patients

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Brescia
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 99 Years
Countries
Italy
Sponsor
Aziende Chimiche Riunite Angelini Francesco S.p.A
Condition
Schizophrenia
Behavioral study icon
TerminatedNCT02746965

Magnetic Seizure Therapy for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Shanghai
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 55 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia
Behavioral study icon
CompletedNCT07130227

MBRS-Based Psychoeducation in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Erzurum
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 60 Years
Countries
Türkiye
Sponsor
Ataturk University
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.